Worldwide, there are plants known as psychoactive plants that naturally contain psychedelic active components. They have a high concentration of neuroprotective substances that can interact with the nervous system to produce psychedelic effects. Despite these plants' hazardous potential, recreational use of them is on the rise because of their psychoactive properties. Early neuroscience studies relied heavily on psychoactive plants and plant natural products (NPs), and both recreational and hazardous NPs have contributed significantly to the understanding of almost all neurotransmitter systems. Worldwide, there are many plants that contain psychoactive properties, and people have been using them for ages. Psychoactive plant compounds may significantly alter how people perceive the world.
1. Langmuir. 2024 Jun 11;40(23):12264-12275. doi: 10.1021/acs.langmuir.4c01403. Epub 2024 May 28. Stability of Liposomal Membrane of Hemoglobin-Vesicles (Artificial Red Cells) for Over Years of Storage Evaluated Using Liquid Chromatography-Mass Spectrometry. Kure T(1), Ochiai R(2), Sakai H(1). Author information: (1)Department of Chemistry, Nara Medical University, 840 Shijo-cho, Kashihara 634-8521, Japan. (2)Pharmaceuticals and Life Sciences Division, Shimadzu Techno-Research, Inc., Kyoto 604-8436, Japan. Hemoglobin-Vesicles (Hb-V) are artificial oxygen carriers encapsulating a purified and concentrated Hb solution in liposomes composed of 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine (DPPC), cholesterol, 1,5-O-dihexadecyl-N-succinyl-l-glutamate (DHSG), and 1,2-distearoyl-sn-glycero-3-phosphatidylethanolamine-N-poly(ethylene glycol) (PEG5000) (DSPE-PEG). The safety and efficacy of Hb-V have been studied extensively by both preclinical and clinical test methods. Deoxygenation of Hb-V prevents autoxidation of Hb and can extend its shelf life to 2 years at room temperature. However, the lipid components raise concerns about hydrolysis because Hb-V is dispersed in saline. For this study, we attempted to estimate the lipid degradation of long-term stored Hb-V using liquid chromatography-mass spectrometry. Analyses of lipid components extracted from the stored Hb-V showed that the degradation increased depending on the storage temperature. The calculated % remaining of intact lipids of Hb-V were 98.1% after 4 years and 90.4% after 7.2 years at 4 °C, 95.8% after 1 year and 86.7% after 2 years at 25 °C, and 85.6% after 6 months at 40 °C. The main degradation products were lyso-PC and palmitic acid which are hydrolyzed at the ester bond of DPPC. A few hydrolyzed products of DHSG and DSPE-PEG were also detected in Hb-V, but almost no degradation or oxidation products derived from cholesterol could be identified. A shear test of Hb-V at 1500 s-1 showed no significant increase in Hb leakage after storage of 2 years at 25 °C and 6 months at 40 °C. Lipid degradation products including free fatty acids would decrease the pH of the Hb-V dispersion and synergistically facilitate degradation, but it maintained pH 6.5 during 6 years at 4 °C, 2 years at 25 °C, and 3 months at 40 °C because of its high buffering capacity. These results indicate that the storage conditions for Hb-V are appropriate to minimize lipid degradation in the long term. DOI: 10.1021/acs.langmuir.4c01403 PMID: 38804272 [Indexed for MEDLINE] 2. J Phys Chem B. 2023 Apr 20;127(15):3505-3515. doi: 10.1021/acs.jpcb.2c08412. Epub 2023 Apr 5. Relevance of Surface Adsorption and Aqueous Complexation for the Separation of Co(II), Ni(II), and Fe(III). Sun P(1)(2), Binter EA(1), Vo T(1), Benjamin I(3), Bera MK(2), Lin B(2), Bu W(2), Schlossman ML(1). Author information: (1)Department of Physics, University of Illinois at Chicago, Chicago, Illinois 60607, United States. (2)NSF's ChemMatCARS, Pritzker School of Molecular Engineering, University of Chicago, Chicago, Illinois 60637, United States. (3)Department of Chemistry and Biochemistry, University of California, Santa Cruz, California 95064, United States. During the solvent extraction of metal ions from an aqueous to an organic phase, organic-soluble extractants selectively target aqueous-soluble ions for transport into the organic phase. In the case of extractants that are also soluble in the aqueous phase, our recent studies of lanthanide ion-extractant complexes at the surface of aqueous solutions suggested that ion-extractant complexation in the aqueous phase can hinder the solvent extraction process. Here, we investigate a similar phenomenon relevant to the separation of Co(II), Ni(II), and Fe(III). X-ray fluorescence near total reflection and tensiometry are used to characterize ion adsorption behavior at the surface of aqueous solutions containing water-soluble extractants, either bis(2-ethylhexyl) phosphoric acid (HDEHP) or 2-ethylhexylphosphonic acid mono-2-ethylhexyl ester (HEHEHP), as well as adsorption to a monolayer of water-insoluble extractant dihexadecyl phosphoric acid (DHDP) at the aqueous-vapor interface. Competitive adsorption of Ni(II) and Fe(III) utilizing either HDEHP or DHDP illustrates the essential feature of the recent lanthanide studies that the ion, which is preferentially extracted in liquid-liquid extraction, Fe(III), is found preferentially adsorbed to the water-vapor interface only in the presence of the water-insoluble extractant DHDP. A more subtle competition produces comparable adsorption behavior of Co(II) and Ni(II) at the surfaces of both HDEHP- and HEHEHP-aqueous solutions in spite of the known preference for Co(II) under solvent extraction conditions. Comparison experiments with a monolayer of DHDP reveal that Co(II) is preferentially adsorbed to the surface. This preference for Co(II) is also supported by molecular dynamics simulations of the potential of mean force of ions interacting with the soluble extractants in water. These results highlight the possibility that complexation of extractants and ions in the aqueous phase can alter selectivity in the solvent extraction of critical elements. DOI: 10.1021/acs.jpcb.2c08412 PMID: 37018762 3. Protein Expr Purif. 2016 Aug;124:62-7. doi: 10.1016/j.pep.2016.05.015. Epub 2016 May 27. Impact of purification conditions and history on A2A adenosine receptor activity: The role of CHAPS and lipids. Naranjo AN(1), McNeely PM(1), Katsaras J(2), Robinson AS(3). Author information: (1)Department of Chemical and Biomolecular Engineering, University of Delaware, Newark, DE 19711, United States. (2)Biology and Soft Matter Division, Neutron Sciences Directorate, Oak Ridge National Laboratory, Oak Ridge, TN 37831-6100, United States; Department of Physics and Astronomy, The University of Tennessee, Knoxville, TN 37996-1200, United States; Joint Institute for Neutron Sciences, Oak Ridge National Laboratory, Oak Ridge, TN 37831-6453, United States. (3)Department of Chemical and Biomolecular Engineering, University of Delaware, Newark, DE 19711, United States; Department of Chemical and Biomolecular Engineering, 300 Lindy Boggs Laboratory, Tulane University, New Orleans, LA 70118, United States. Electronic address: asr@tulane.edu. The adenosine A2A receptor (A2AR) is a much-studied class A G protein-coupled receptor (GPCR). For biophysical studies, A2AR is commonly purified in a detergent mixture of dodecylmaltoside (DDM), 3-(3-cholamidopropyl) dimethylammoniopropane sulfonate (CHAPS), and cholesteryl hemisuccinate (CHS). Here we studied the effects of CHAPS on the ligand binding activity and stability of wild type, full-length human A2AR. We also tested the cholesterol requirement for maintaining the active conformation of the receptor when solubilized in detergent micelles. To this end, the receptor was purified using DDM, DDM/CHAPS, or the short hydrocarbon chain lipid 1,2-dihexanoyl-sn-glycero-3-phosphocholine (DHPC, di-6:0PC). After solubilization in DDM, DDM/CHAPS, or DHPC micelles, although A2AR was found to retain its native-like fold, its binding ability was significantly compromised compared to DDM or DDM/CHAPS with CHS. It therefore appears that although cholesterol is not needed for A2AR to retain a native-like, α-helical conformation, it may be a critical component for high affinity ligand binding. Further, this result suggests that the conformational differences between the active and inactive protein may be so subtle that commonly used spectroscopic methods are unable to differentiate between the two forms, highlighting the need for activity measurements. The studies presented in this paper also underline the importance of the protein's purification history; i.e., detergents that interact with the protein during purification affect the ligand binding properties of the receptor in an irreversible manner. Copyright © 2016 Elsevier Inc. All rights reserved. DOI: 10.1016/j.pep.2016.05.015 PMCID: PMC4947529 PMID: 27241126 [Indexed for MEDLINE] 4. Mol Pharm. 2014 Nov 3;11(11):4238-48. doi: 10.1021/mp500453a. Epub 2014 Oct 6. Therapeutic impact of erythropoietin-encapsulated liposomes targeted to bone marrow on renal anemia. Miyazaki Y(1), Taguchi K, Sou K, Watanabe H, Ishima Y, Miyakawa T, Mitsuya H, Fukagawa M, Otagiri M, Maruyama T. Author information: (1)Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University , Kumamoto 862-0973, Japan. Bone marrow is a key element in the diagnosis of disorders of erythropoiesis, including anemia, and a potential target in their treatment. However, because efficient delivery of diagnostic and therapeutic agents to bone marrow is difficult, such delivery is achieved by administering drugs in large quantities that often have adverse effects. Here, we achieved selective delivery of recombinant human erythropoietin (rHuEPO) to bone marrow, via its encapsulation in liposomes with l-glutamic acid, N-(3-carboxy-1-oxopropyl)-, 1,5-dihexadecyl ester (SA) (liposome-EPO). The result, in a rabbit model of renal anemia, was a beneficial effect on hematopoiesis, better than with rHuEPO alone. Also, we determined that liposome-EPO delivery to bone marrow depended on specific uptake by bone marrow macrophages because of the presence of SA. These results indicate both that liposome-EPO is a new, promising erythropoietin-stimulating agent and that liposomes with SA have potential for diagnostic and therapeutic applications in diseases originating from bone marrow. DOI: 10.1021/mp500453a PMID: 25255196 [Indexed for MEDLINE] 5. Chem Asian J. 2006 Dec 18;1(6):780-8. doi: 10.1002/asia.200600206. Asymmetric resolution in ester reduction by NaBH4 at the interface of aqueous aggregates of amino acid, peptide, and chiral-counterion-based cationic surfactants. Dasgupta A(1), Mitra RN, Roy S, Das PK. Author information: (1)Department of Biological Chemistry, Indian Association for the Cultivation of Science, Jadavpur, Kolkata 700032, India. This study provides insight into the physicochemical aspects of aqueous aggregates that comprise amino acid, peptide, and chiral-counterion-based cationic surfactants and their correlation with the proficiency of asymmetric resolution in ester reduction. The effects of the structural differences in the naturally occurring amino acid based and synthetic chiral-counterion-containing gemini surfactants on the surface properties as well as on other microstructural parameters were studied and correlated to the varied head groups of the surfactants. The supramolecular chirality induced from the head-group region of chiral amphiphiles in aqueous self-aggregates is evident from circular dichroism, scanning electron microscopy, and transmission electron microscopy studies. This large-scale chirality at the interface of self-aggregates was exploited towards asymmetric resolution in ester reduction by NaBH4. An enantiomeric excess of 53% ((R)-2-phenylpropan-1-ol) was found in the case of the n-hexyl ester of 2-phenylpropionic acid as substrate in the aqueous aggregate of N,N'-dihexadecyl-N,N,N',N'-tetramethyl-N,N'-ethanediyldiammonium diquinate. Thus, a simple and environmentally benign pathway for asymmetric resolution in ester reduction by sodium borohydride alone is reported, which utilizes the varied spatial asymmetry at the interface of aqueous aggregates of cationic chiral amphiphiles. DOI: 10.1002/asia.200600206 PMID: 17441121 [Indexed for MEDLINE]